CVE-2017-14006GE Xeleris versions 1.0,1.1,2.1,3.0,3.1, medical imaging systems, all current versions are affected, these devices use default or hard-coded credentials.
Updated under an hour ago ()
Does this affect you?
It affects GE Healthcare GE Xeleris and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 1.86%, higher than 79% of scored CVEs.
Do this next
Free account, 1 product
GE Xeleris versions 1.0,1.1,2.1,3.0,3.1, medical imaging systems, all current versions are affected, these devices use default or hard-coded credentials. Successful exploitation of this vulnerability may allow a remote attacker to bypass authentication and gain access to the affected devices.
- CVSS
- 9.8 CRITICAL (v3.0, NVD)CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-287
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 1.86% (percentile 79)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Sep 16, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
GE Healthcare GE Xeleris ge_healthcare:ge_xeleris (from the name) | 1.0,1.1,2.1,3.0,3.1 | CNA record |
ge xeleris ge:xeleris | 1.0; 1.1; 2.1; 3.0; 3.1 | NVD |
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-037-02x-refsource-misc, mitigation, third-party-advisory, us-government-resource
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.